Articles citing this paper
Cost–benefit analysis of enhancing the uptake of long-acting reversible contraception in Australia
Kristine Concepcion A , Sarina Lacey B , Kevin McGeechan A C , Jane Estoesta A , Deborah Bateson A and Jessica Botfield A D
+ Author Affiliations
- Author Affiliations
A Family Planning NSW, 328–336 Liverpool Road, Ashfield, NSW 2131, Australia. Email: kris.alba@gmail.com; kevinm@fpnsw.org.au; janee@fpnsw.org.au; deborahb@fpnsw.org.au
B The Centre for International Economics, Level 7, 8 Spring Street, Sydney, NSW 2000, Australia. Email: slacey@thecie.com.au
C School of Public Health, The University of Sydney, Edward Ford Building (A27), Fisher Road, Sydney, NSW 2006, Australia.
D Corresponding author. Email: jessicab@fpnsw.org.au
Australian Health Review 44(3) 385-391 https://doi.org/10.1071/AH18190
Submitted: 20 September 2018 Accepted: 8 July 2019 Published: 28 October 2019
8 articles found in Crossref database.
Rethinking referral pathways: qualitative evaluation of general practice networks to increase access to intrauterine contraception
Bell Sara F E,
Harvey Caroline,
Mack Fiona,
Lambert Stephen,
Lazarou Mattea,
Strom Kay, Dean Judith A
Family Practice. 2022 39(6). p.1109
An exploration of the contraceptive counselling practices of midwives who provide postpartum care in Australia
Cheney Kate,
Mignacca Emily,
Black Kirsten I,
Homer Caroline, Bradfield Zoe
Midwifery. 2024 131 p.103948
Development of a pharmacoeconomic registry: an example using hormonal contraceptives
White Annesha,
Srinivasan Meenakshi,
Wingate La Marcus,
Peasah Samuel, Fleming Marc
Health Economics Review. 2021 11(1).
Cost-effectiveness of a complex intervention in general practice to increase uptake of long-acting reversible contraceptives in Australia
Lewandowska Milena,
De Abreu Lourenco Richard,
Haas Marion,
Watson Cathy J.,
Black Kirsten I.,
Taft Angela,
Lucke Jayne,
McGeechan Kevin,
McNamee Kathleen,
Peipert Jeffrey F., Mazza Danielle
Australian Health Review. 2021 45(6). p.728
Medicaid Cost Savings from Provision of Contraception to Beneficiaries in South Carolina, 2012–2018
Manalew W. Samuel,
Hale Nathan,
Leinaar Edward,
Sen Bisakha,
Smith Michael, Khoury Amal
Population Health Management. 2022 25(4). p.542
Barriers to prescribing of long‐acting reversible contraception (LARC) by general practitioner registrars: A cross‐sectional questionnaire
Turner Rachel,
Tapley Amanda,
Sweeney Sally, Magin Parker
Australian and New Zealand Journal of Obstetrics and Gynaecology. 2021 61(3). p.469
A Cost Effectiveness Model of Long-Acting Reversible Contraceptive Methods in the Brazilian National Health System
Farah Daniela,
de Moraes Andrade Teresa Raquel,
Sansone Dayan,
Batista Castello Girão Manoel João, Fonseca Marcelo Cunio Machado
American Journal of Preventive Medicine. 2022 62(1). p.114
Changes in use of hormonal long‐acting reversible contraceptive methods in Australia between 2006 and 2018: A population‐based study
Grzeskowiak Luke E.,
Calabretto Helen,
Amos Natalie,
Mazza Danielle, Ilomaki Jenni
Australian and New Zealand Journal of Obstetrics and Gynaecology. 2021 61(1). p.128
